Labelling pathological tau: an important quest for the unknown

Labelling pathological tau: an important quest for the unknown

Bibliographic Details
Main Author:	Irving E Vega
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-06-01
Series:	Frontiers in Neuroscience
Subjects:	brain imaging Alzheimer’s disease tau Tauopathy fluorescent fibrillary tau dye
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnins.2016.00253/full

Similar Items

Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
by: Aleksandra M. Wojtas, et al.
Published: (2020-12-01)

Editorial: Tau Pathology in Neurological Disorders
by: Sonia Do Carmo, et al.
Published: (2021-09-01)

Intracellular and extracellular tau
by: Jesus Avila, et al.
Published: (2010-06-01)

Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
by: Antoine Duquette, et al.
Published: (2021-01-01)

The Significance of Tau Aggregates in the Human Brain
by: Rudy J. Castellani
Published: (2020-12-01)

Pharmacological Modulators of Tau Aggregation and Spreading
by: Antonio Dominguez-Meijide, et al.
Published: (2020-11-01)

Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us?
by: Sarah Houben, et al.
Published: (2021-02-01)

Differences Between Human and Murine Tau at the N-terminal End
by: Félix Hernández, et al.
Published: (2020-01-01)

Editorial: Untangling the Role of Tau in Physiology and Pathology
by: Miguel Medina, et al.
Published: (2020-05-01)

Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan
by: Chun-Wei Chang, et al.
Published: (2014-06-01)

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
by: Garrett S. Gibbons, et al.
Published: (2020-11-01)

Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology
by: Carmen Romero-Molina, et al.
Published: (2018-11-01)

Filamentous Aggregates of Tau Proteins Fulfil Standard Amyloid Criteria Provided by the Fuzzy Oil Drop (FOD) Model
by: Dawid Dułak, et al.
Published: (2018-09-01)

Tau’s Three-Repeat Domain and EFhd2 Co-incubation Leads to Increased Thioflavin Signal
by: Irving E. Vega, et al.
Published: (2018-12-01)

Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
by: Elisa Canepa, et al.
Published: (2021-01-01)

Microglia in Alzheimer’s Disease in the Context of Tau Pathology
by: Juan Ramón Perea, et al.
Published: (2020-10-01)

Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel
by: Or A. Shemesh, et al.
Published: (2011-07-01)

Extracellular Tau and Its Potential Role in the Propagation of Tau Pathology
by: Kaoru Yamada
Published: (2017-11-01)

Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model
by: YoungDoo Kim, et al.
Published: (2016-03-01)

Formation and propagation of tau oligomeric seeds
by: Julia E. Gerson, et al.
Published: (2013-07-01)

Modulation der Tau-Aggregation durch Modifikation der Cystein-Reste im Tau-Protein
by: Karras, Stephanie
Published: (2017)

Physiological and pathological phosphorylation of tau by Cdk5
by: Taeko eKimura, et al.
Published: (2014-07-01)

The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?
by: Yann Fichou, et al.
Published: (2019-03-01)

Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
by: Sebastian S. Oakley, et al.
Published: (2020-11-01)

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
by: Chun-ling Dai, et al.
Published: (2018-01-01)

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-03-01)

Tau oligomers
by: Naruhiko eSahara, et al.
Published: (2014-01-01)

Mutant three-repeat tau expression initiates retinal ganglion cell death through Caspase-2
by: Jennifer Ngolab, et al.
Published: (2021-05-01)

Neurons Expressing Pathological Tau Protein Trigger Dramatic Changes in Microglial Morphology and Dynamics
by: Rahma Hassan-Abdi, et al.
Published: (2019-11-01)

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
by: Garrett S. Gibbons, et al.
Published: (2019-03-01)

Targeting tauopathy with engineered tau-degrading intrabodies
by: Gilbert Gallardo, et al.
Published: (2019-10-01)

New Features about Tau Function and Dysfunction
by: Miguel Medina, et al.
Published: (2016-04-01)

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
by: Juan R. Perea, et al.
Published: (2018-07-01)

Pathogenic Tau Causes a Toxic Depletion of Nuclear Calcium
by: Rebekah Mahoney, et al.
Published: (2020-07-01)

Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
by: Huiqin Zhang, et al.
Published: (2021-07-01)

Much More Than a Cytoskeletal Protein: Physiological and Pathological Functions of the Non-microtubule Binding Region of Tau
by: Roland Brandt, et al.
Published: (2020-10-01)

Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity
by: Luciana Medina, et al.
Published: (2021-03-01)

What is the evidence that tau pathology spreads through prion-like propagation?
by: Amrit Mudher, et al.
Published: (2017-12-01)

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
by: Jakub Sinsky, et al.
Published: (2021-08-01)

Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
by: Pankajavalli Ramakrishnan, et al.
Published: (2003-11-01)